Yi-wen Huang
1, 3 Sec, Chung Hsiao E. Rd
Taipei, TNQ 10608, Taiwan
Taipei, TNQ 10608, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.
Journal: Hepatology international
Published: June 09, 2026
Impact of tenofovir vs. entecavir treatment on progression of chronic hepatitis B: A nationwide cohort study.
Journal: JHEP reports : innovation in hepatology
Published: February 11, 2025
Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history.
Journal: Journal of gastroenterology
Published: July 14, 2024
Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-up.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 21, 2024
Pueraria montana var. lobata Root Extract Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Increasing Mitochondrial β-Oxidation and Mitochondrial-Peroxisome Contact.
Journal: Phytotherapy research : PTR
Published: January 21, 2024
Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
Journal: Journal of medical virology
Published: June 05, 2023
A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatment.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: February 21, 2023
Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
Journal: Cancers
Published: October 21, 2022
Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.
Journal: Pharmaceutics
Published: August 22, 2022
A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: June 28, 2022
Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis.
Journal: Viruses
Published: April 22, 2022
Simultaneous determination of 24 congeners of 2- and 3-monochloropropanediol esters and 7 congeners of glycidyl esters using direct multi-residue analytical LC-MS/MS methods in various food matrices.
Journal: Journal of food and drug analysis
Published: March 28, 2022
Last Updated: 09/26/2026